EDEN PRAIRIE, Minn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that Claudia Drayton,
Chief Financial Officer will be a featured presenter at the LD Micro 10th Annual Main Event on Tuesday, December 5, 2017 at 9:30 AM
Pacific Time. The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Ms. Drayton will provide an
overview of the company’s business model and growth strategy and will be available for one-on-one meetings.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for
Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of
patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a
healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's
objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware
corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been
listed on the NASDAQ Capital Market since February 2012.
For further information, please contact: Claudia Napal Drayton Chief Financial Officer CHF Solutions, Inc. T: +1-952-345-4205 Investor Relations CHF Solutions, Inc. ir@chf-solutions.com -or- Bret Shapiro CORE IR 516 222 2560 brets@coreir.com www.coreir.com
